A 2020 TOP DOC
Dr. Armando Sardi is a respected and renowned cancer surgeon as well as the Medical Director of The Institute for Cancer Care at Mercy and as Chief of Surgical Oncology at Mercy.
Inflammatory bowel disease, or IBD, includes disorders that cause inflammation of the intestines. IBD is treated at Mercy by expert gastroenterologists.
The surgeons of The Center for Minimally Invasive Surgery at Mercy treat a variety of conditions including gallbladder disease, gallstones, hernia, colon cancer and GERD.
Mercy offers emergency care on the Downtown Baltimore campus 24 hours a day, 7 days a week (410-332-9477) with access to a trained emergency medicine team, diagnostic services and consultations with specialists.
In case of an Emergency, Dial 911 and follow the instructions of the EMS (Emergency Medical Services) team.
Mercy Medical Center's downtown campus includes our Main Hospital - The Mary Catherine Bunting Center, McAuley Plaza and The Weinberg Center.
General visiting hours at Mercy are 11:00 am to 8:30 pm. Hours vary by floor, please check with the nursing staff or call 410-332-9555.
The cancer surgeons of Surgical Oncology at Mercy are recognized experts in performing cytoreductive surgery in conjunction with hyperthermic intraperitoneal chemotherapy (HIPEC) to treat advanced stages of abdominal cancer.
Cytoreductive surgery is the aggressive removal or destruction of the visible tumors in the abdomen. Performing cytoreductive surgery requires the expertise of an experienced surgeon. The length of the surgery depends on the amount of disease that is present.
The goal of cytoreductive surgery is to remove the visible tumors in the abdominal or stomach cavity. In some cases, microscopic cancer cells may be left behind. To prevent these cells from growing into larger tumors in the abdomen, the surgery is then followed by HIPEC.
Cytoreductive surgery performed in conjunction with HIPEC is a procedure for patients with peritoneal carcinomatosis (cancer in the abdomen area) that originated in the colon, rectum, stomach, appendix and ovaries, as well as mesotheliomas, sarcomas and primary peritoneal cancers.
Mercy’s cancer surgeons and their clinical team are recognized nationally as leaders in aggressive cytoreductive surgery and HIPEC. Due to the complexity of the combined therapies, surgeons must be appropriately trained and experienced to offer these treatment methods.
The Surgical Oncology team at Mercy in Baltimore performs these procedures on a frequent basis and offers a high level of expertise to patients facing a diagnosis of peritoneal cancer.
Surgical Oncology at Mercy Medical Center in Baltimore, Maryland, treats a broad range of cancers and benign tumors including colon and rectal cancer, liver cancer, pancreatic cancer, thyroid cancer, sarcoma and melanoma. Mercy's surgical oncologists utilize modern medical technologies such as laparoscopy, brachytherapy, hyperthermic intraperitoneal chemotherapy (HIPEC) and microwave ablation to help eliminate tumors with minimal damage to healthy tissue.
Surgical Oncology is part of The Institute for Cancer Care at Mercy Medical Center.
Dr. Vadim Gushchin, Director of Mercy's prestigious HIPEC Program, is among the region’s leading surgical oncologists, offering long-time expertise in the treatment of complex cancers.
A Mercy patient says she believes in miracles after being diagnosed with primary peritoneal cancer and given a second chance at life.